| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/17/1998 | US5718902 Double recombinant vaccinia virus vaccines |
| 02/17/1998 | US5718901 Polypeptide |
| 02/17/1998 | US5718900 Vaccines and methods for preventing and treating Fescue toxicosis in herbivores |
| 02/17/1998 | US5718899 High concentration of immunoglobulins |
| 02/12/1998 | WO1998005787A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/12/1998 | WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
| 02/12/1998 | WO1998005775A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | WO1998005755A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/12/1998 | WO1998005687A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 02/12/1998 | WO1998005682A2 Peptides corresponding or imitating at least one antigenic determinant of the hamagglutinin protein of mobillivirus |
| 02/12/1998 | WO1998005365A2 Compositions and methods for disinfecting contact lenses and preserving contact lens care products |
| 02/12/1998 | WO1998005357A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 02/12/1998 | WO1998005356A1 NOVEL FtsL |
| 02/12/1998 | WO1998005355A1 Vaccine composition against malaria |
| 02/12/1998 | WO1998005350A1 Materials and methods for treatment of plaquing diseases |
| 02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
| 02/12/1998 | WO1998005348A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 02/12/1998 | WO1998005346A1 Herbal formulation and therapeutic uses therefor |
| 02/12/1998 | WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 02/12/1998 | WO1997045139A3 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 02/12/1998 | WO1997034599A3 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 02/12/1998 | WO1997019111A3 Monoclonal antibodies anti-cd6 and their uses |
| 02/12/1998 | CA2791778A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
| 02/12/1998 | CA2262459A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | CA2262415A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | CA2262405A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/12/1998 | CA2262402A1 Vaccine composition against malaria |
| 02/12/1998 | CA2233987A1 Materials and methods for treatment of plaquing diseases |
| 02/12/1998 | CA2233570A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0823438A2 Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 02/11/1998 | EP0822987A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 02/11/1998 | EP0822985A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| 02/11/1998 | EP0822980A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 02/11/1998 | EP0822979A1 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same |
| 02/11/1998 | EP0822977A1 Modified cells and methods for inhibiting xenograft rejection |
| 02/11/1998 | EP0822942A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation |
| 02/11/1998 | EP0822941A1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
| 02/11/1998 | EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection |
| 02/11/1998 | EP0822831A1 Vaccines containing a saponin and a sterol |
| 02/11/1998 | EP0822830A1 Human antibodies derived from immunized xenomice |
| 02/11/1998 | EP0822828A1 Isolated 55 to 75 kda protein which binds to prion protein |
| 02/11/1998 | CN1173204A Immunogens for stimulating mucosal immunity |
| 02/11/1998 | CN1173203A Purified papillomavirus proteins |
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/10/1998 | US5717074 Macrophage-derived inflammatory mediator (MIP-2) |
| 02/10/1998 | US5717073 Anti-gp130 monoclonal antibodies |
| 02/10/1998 | US5717071 Culture product bactericide specific binding to lipopolysaccharide of outer membrane for treating bacterial infection |
| 02/10/1998 | US5717065 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| 02/10/1998 | US5716934 Eck receptor ligands |
| 02/10/1998 | US5716930 Polypeptide from genetically engineered cells |
| 02/10/1998 | US5716848 Cultured cells of quillaja sp |
| 02/10/1998 | US5716832 Growing packaging cells having viral protein-coding sequences which produce target cell-specific retroviruses; gene therapy, antitumor agents |
| 02/10/1998 | US5716828 Kit for detecting the ApoE4 allele, and for diagnosing the existence or risk of developing Alzheimer's disease |
| 02/10/1998 | US5716826 Recombinant retroviruses |
| 02/10/1998 | US5716823 Human respiratory virus preparahons and processess |
| 02/10/1998 | US5716822 Feline calicivirus capsid gene and protein |
| 02/10/1998 | US5716821 Pure, recombinant virus particles comprising respiratory syncytial virus rna dependent rna polymerase, a phosphoprotein, a nucleocapsid, a structural protein, rna sequences; vaccines |
| 02/10/1998 | US5716793 Immunocomplexing |
| 02/10/1998 | US5716792 Streptococcus suis adhesin protein and method for producing it |
| 02/10/1998 | US5716778 Concentrating immunochemical test device and method |
| 02/10/1998 | US5716620 Vaccines, diagnostic immunoassay |
| 02/10/1998 | US5716613 Genetic engineering |
| 02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
| 02/10/1998 | CA2053258C Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption |
| 02/10/1998 | CA1339670C Polyamide resin and resin-protide, and methods for preparation of reagents and of immunodiagnostic testing |
| 02/05/1998 | WO1998004917A1 Boron neutron capture therapy using pre-targeting methods |
| 02/05/1998 | WO1998004728A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | WO1998004720A1 Method and reagents for genetic immunization |
| 02/05/1998 | WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 02/05/1998 | WO1998004711A2 Desaturase antigen of mycobacterium tuberculosis |
| 02/05/1998 | WO1998004710A2 Live recombinant bhv/brsv vaccine |
| 02/05/1998 | WO1998004709A2 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 02/05/1998 | WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 02/05/1998 | WO1998004703A1 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN |
| 02/05/1998 | WO1998004702A2 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004684A1 Recombinant swinepox virus |
| 02/05/1998 | WO1998004588A1 Lymphocyte stimulating factor from trypanosoma |
| 02/05/1998 | WO1998004585A2 Novel human macrophage antigen |
| 02/05/1998 | WO1998004582A1 Isolated peptides derived from mage-2 |
| 02/05/1998 | WO1998004576A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | WO1998004287A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 02/05/1998 | WO1998004286A2 Assembly-deficient herpesvirus vaccine |
| 02/05/1998 | WO1998004285A1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression |
| 02/05/1998 | WO1998004284A1 Novel genes of kaposi's sarcoma associated herpesvirus |
| 02/05/1998 | WO1998004283A1 Antiprotozoal composition |
| 02/05/1998 | WO1998004282A1 Cancer immunotherapy using autologous tumor cells combined with allogeneic cytokine-secreting cells |
| 02/05/1998 | WO1998004281A1 Improved method of treating immune cell mediated systemic diseases |
| 02/05/1998 | WO1998004274A1 Recombinant mosquito salivary allergens |
| 02/05/1998 | WO1998004273A1 Method for treating gastrointestinal damage |
| 02/05/1998 | WO1997033912A3 Uses of gdnf and gdnf receptor |
| 02/05/1998 | CA2297955A1 Lymphocyte stimulating factor from trypanosoma |
| 02/05/1998 | CA2262013A1 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 02/05/1998 | CA2262006A1 Method and reagents for genetic immunization |
| 02/05/1998 | CA2261990A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | CA2261837A1 Cancer immunotherapy using autologous tumor cells combined with allogeneic cytokine-secreting cells |